Clinical Trial Update: A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 study evaluating the NeoVista Ophthalmic System for treating subfoveal CNV associated with wet age-related macular degeneration in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• Neovista Ophthalmic System

Snippet

Sponsor: NeoVista | Conditions: Age Related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN